Bronchoalveolar lavage fluid cfDNA liquid biopsy-guided neoadjuvant lazertinib in resectable EGFR-mutant non-small cell lung cancer: a prospective phase II study
- DOI
- 10.21037/tlcr-2026-0915
- Published
- 2026-10
- Container
- Translational Lung Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2026-0915,
title = {Bronchoalveolar lavage fluid cfDNA liquid biopsy-guided neoadjuvant lazertinib in resectable EGFR-mutant non-small cell lung cancer: a prospective phase II study},
author = {In Ae Kim and Heejoung Kim and Jae Young Hur and Wan Seop Kim and Young Whan Kim and Song Am Lee and Jae Joon Hwang and Kye Young Lee},
year = {2026},
journal = {Translational Lung Cancer Research},
doi = {10.21037/tlcr-2026-0915},
url = {https://doi.org/10.21037/tlcr-2026-0915}
}RIS
TY - JOUR TI - Bronchoalveolar lavage fluid cfDNA liquid biopsy-guided neoadjuvant lazertinib in resectable EGFR-mutant non-small cell lung cancer: a prospective phase II study AU - In Ae Kim AU - Heejoung Kim AU - Jae Young Hur AU - Wan Seop Kim AU - Young Whan Kim AU - Song Am Lee AU - Jae Joon Hwang AU - Kye Young Lee PY - 2026 JO - Translational Lung Cancer Research DO - 10.21037/tlcr-2026-0915 UR - https://doi.org/10.21037/tlcr-2026-0915 ER -
APA
Kim, I. A., Kim, H., Hur, J. Y., Kim, W. S., Kim, Y. W., Lee, S. A., Hwang, J. J., & Lee, K. Y. (2026). Bronchoalveolar lavage fluid cfDNA liquid biopsy-guided neoadjuvant lazertinib in resectable EGFR-mutant non-small cell lung cancer: a prospective phase II study. Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-2026-0915
Source records
- crossref · retrieved 2026-11-09T08:00:56.567Z